Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

SLAMF6 as a Regulator of Exhausted CD8+ T Cells in Cancer.

Yigit B, Wang N, Ten Hacken E, Chen SS, Bhan AK, Suarez-Fueyo A, Katsuyama E, Tsokos GC, Chiorazzi N, Wu CJ, Burger JA, Herzog RW, Engel P, Terhorst C.

Cancer Immunol Res. 2019 Sep;7(9):1485-1496. doi: 10.1158/2326-6066.CIR-18-0664. Epub 2019 Jul 17.

PMID:
31315913
2.

Risk factors for cytomegalovirus infection in patients with antineutrophil cytoplasmic antibody-associated vasculitis.

Morishita M, Sada KE, Matsumoto Y, Hayashi K, Asano Y, Hiramatsu Asano S, Ohashi K, Miyawaki Y, Katsuyama E, Watanabe H, Kawabata T, Wada J.

PLoS One. 2019 Jul 10;14(7):e0218705. doi: 10.1371/journal.pone.0218705. eCollection 2019.

3.

Pyruvate kinase M2 is requisite for Th1 and Th17 differentiation.

Kono M, Maeda K, Stocton-Gavanescu I, Pan W, Umeda M, Katsuyama E, Burbano C, Orite SYK, Vukelic M, Tsokos MG, Yoshida N, Tsokos GC.

JCI Insight. 2019 Jun 20;4(12). pii: 127395. doi: 10.1172/jci.insight.127395. eCollection 2019 Jun 20.

4.

Regulation of Cathepsin E gene expression by the transcription factor Kaiso in MRL/lpr mice derived CD4+ T cells.

Hiramatsu S, Watanabe KS, Zeggar S, Asano Y, Miyawaki Y, Yamamura Y, Katsuyama E, Katsuyama T, Watanabe H, Takano-Narazaki M, Matsumoto Y, Kawabata T, Sada KE, Wada J.

Sci Rep. 2019 Feb 28;9(1):3054. doi: 10.1038/s41598-019-38809-y.

5.

Simultaneous presence of lung adenocarcinoma and malignant pleural mesothelioma: A case report.

Yamazoe M, Tomioka H, Kamada T, Kaneko M, Katsuyama E.

Respir Med Case Rep. 2018 Nov 19;26:45-49. doi: 10.1016/j.rmcr.2018.11.011. eCollection 2019.

6.

Signaling Lymphocytic Activation Molecule Family Member 1 Engagement Inhibits T Cell-B Cell Interaction and Diminishes Interleukin-6 Production and Plasmablast Differentiation in Systemic Lupus Erythematosus.

Karampetsou MP, Comte D, Suárez-Fueyo A, Katsuyama E, Yoshida N, Kono M, Kyttaris VC, Tsokos GC.

Arthritis Rheumatol. 2019 Jan;71(1):99-108. doi: 10.1002/art.40682.

PMID:
30058241
7.

Metabolomics-based profiles predictive of low bone mass in menopausal women.

Miyamoto T, Hirayama A, Sato Y, Koboyashi T, Katsuyama E, Kanagawa H, Fujie A, Morita M, Watanabe R, Tando T, Miyamoto K, Tsuji T, Funayama A, Soga T, Tomita M, Nakamura M, Matsumoto M.

Bone Rep. 2018 Jun 18;9:11-18. doi: 10.1016/j.bonr.2018.06.004. eCollection 2018 Dec.

8.

Correction: Downregulation of miR-200a-3p, Targeting CtBP2 Complex, Is Involved in the Hypoproduction of IL-2 in Systemic Lupus Erythematosus-Derived T Cells.

Katsuyama E, Yan M, Watanabe KS, Narazaki M, Matsushima S, Yamamura Y, Hiramatsu S, Ohashi K, Watanabe H, Katsuyama T, Zeggar S, Yoshida N, Moulton VR, Tsokos GC, Sada KE, Wada J.

J Immunol. 2018 Aug 1;201(3):1104. doi: 10.4049/jimmunol.1800810. Epub 2018 Jun 25. No abstract available.

9.

Cluster Analysis Using Anti-Aminoacyl-tRNA Synthetases and SS-A/Ro52 antibodies in Patients With Polymyositis/Dermatomyositis.

Ohashi K, Sada KE, Nakai Y, Matsushima S, Asano Y, Hayashi K, Yamamura Y, Hiramatsu S, Miyawaki Y, Morishita M, Katsuyama T, Katsuyama E, Watanabe H, Tatebe N, Narazaki M, Matsumoto Y, Sunahori Watanabe K, Kawabata T, Wada J.

J Clin Rheumatol. 2019 Sep;25(6):246-251. doi: 10.1097/RHU.0000000000000836.

PMID:
29933322
10.

Downregulation of CD3ζ in NK Cells from Systemic Lupus Erythematosus Patients Confers a Proinflammatory Phenotype.

Suárez-Fueyo A, Bradley SJ, Katsuyama T, Solomon S, Katsuyama E, Kyttaris VC, Moulton VR, Tsokos GC.

J Immunol. 2018 May 1;200(9):3077-3086. doi: 10.4049/jimmunol.1700588. Epub 2018 Mar 30.

11.

Role of Lgals9 Deficiency in Attenuating Nephritis and Arthritis in BALB/c Mice in a Pristane-Induced Lupus Model.

Zeggar S, Watanabe KS, Teshigawara S, Hiramatsu S, Katsuyama T, Katsuyama E, Watanabe H, Matsumoto Y, Kawabata T, Sada KE, Niki T, Hirashima M, Wada J.

Arthritis Rheumatol. 2018 Jul;70(7):1089-1101. doi: 10.1002/art.40467. Epub 2018 May 24.

12.

Tumor necrosis factor receptor-associated factor 6 is required to inhibit foreign body giant cell formation and activate osteoclasts under inflammatory and infectious conditions.

Oya A, Katsuyama E, Morita M, Sato Y, Kobayashi T, Miyamoto K, Nishiwaki T, Funayama A, Fujita Y, Kobayashi T, Matsumoto M, Nakamura M, Kanaji A, Miyamoto T.

J Bone Miner Metab. 2018 Nov;36(6):679-690. doi: 10.1007/s00774-017-0890-z. Epub 2017 Dec 22.

PMID:
29273889
13.

Alternative to Rituximab Therapy for a Patient with Ankylosing Spondylitis Who Was Unable to Continue Anti-TNF Therapy.

Katsuyama E, Wakabayashi H, Sada KE, Hiramatsu S, Miyawaki Y, Morishita M, Ohashi K, Watanabe H, Katsuyama T, Zeggar S, Narazaki M, Tatebe N, Sunahori-Watanabe K, Kawabata T, Wada J.

Acta Med Okayama. 2017 Oct;71(5):445-448. doi: 10.18926/AMO/55444.

14.

Central Diabetes Insipidus in Refractory Antineutrophil Cytoplasmic Antibody-associated Vasculitis.

Ohashi K, Morishita M, Watanabe H, Sada KE, Katsuyama T, Miyawaki Y, Katsuyama E, Narazaki M, Tatebe N, Watanabe K, Kawabata T, Wada J.

Intern Med. 2017 Nov 1;56(21):2943-2948. doi: 10.2169/internalmedicine.8683-16. Epub 2017 Sep 25.

15.

Azathioprine Intolerance in Japanese Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis.

Morishita M, Watanabe H, Yan M, Zeggar S, Hiramatsu S, Ohashi K, Miyawaki Y, Katsuyama E, Katsuyama T, Takano Narazaki M, Toyota Tatebe N, Sunahori Watanabe K, Kawabata T, Sada KE, Wada J.

Intern Med. 2017;56(13):1645-1650. doi: 10.2169/internalmedicine.56.8287. Epub 2017 Jul 1.

16.

Anti-high Mobility Group Box 1 Antibody Ameliorates Albuminuria in MRL/lpr Lupus-Prone Mice.

Watanabe H, Watanabe KS, Liu K, Hiramatsu S, Zeggar S, Katsuyama E, Tatebe N, Akahoshi A, Takenaka F, Hanada T, Akehi M, Sasaki T, Sada KE, Matsuura E, Nishibori M, Wada J.

Mol Ther Methods Clin Dev. 2017 May 25;6:31-39. doi: 10.1016/j.omtm.2017.05.006. eCollection 2017 Sep 15.

17.

A retrospective observational study of glucocorticoid-induced diabetes mellitus with IgA nephropathy treated with tonsillectomy plus methylprednisolone pulse therapy.

Miyawaki Y, Katsuyama T, Sada KE, Hiramatsu S, Ohashi K, Morishita M, Katsuyama E, Watanabe H, Takano-Narazaki M, Toyota-Tatebe N, Sunahori-Watanabe K, Kawabata T, Inoue T, Kinomura M, Sugiyama H, Wada J.

PLoS One. 2017 May 31;12(5):e0178018. doi: 10.1371/journal.pone.0178018. eCollection 2017.

18.

Anti-SS-A/Ro antibody positivity as a risk factor for relapse in patients with polymyositis/dermatomyositis.

Tatebe N, Sada KE, Asano Y, Zeggar S, Hiramatsu S, Miyawaki Y, Ohashi K, Morishita M, Katsuyama T, Katsuyama E, Watanabe H, Narazaki M, Watanabe K, Kawabata T, Wada J.

Mod Rheumatol. 2018 Jan;28(1):141-146. doi: 10.1080/14397595.2017.1317377. Epub 2017 May 2.

19.

Downregulation of miR-200a-3p, Targeting CtBP2 Complex, Is Involved in the Hypoproduction of IL-2 in Systemic Lupus Erythematosus-Derived T Cells.

Katsuyama E, Yan M, Watanabe KS, Narazaki M, Matsushima S, Yamamura Y, Hiramatsu S, Ohashi K, Watanabe H, Katsuyama T, Zeggar S, Yoshida N, Moulton VR, Tsokos GC, Sada KE, Wada J.

J Immunol. 2017 Jun 1;198(11):4268-4276. doi: 10.4049/jimmunol.1601705. Epub 2017 Apr 24. Erratum in: J Immunol. 2018 Aug 1;201(3):1104.

20.

A serum metabolomics-based profile in low bone mineral density postmenopausal women.

Miyamoto T, Hirayama A, Sato Y, Koboyashi T, Katsuyama E, Kanagawa H, Miyamoto H, Mori T, Yoshida S, Fujie A, Morita M, Watanabe R, Tando T, Miyamoto K, Tsuji T, Funayama A, Nakamura M, Matsumoto M, Soga T, Tomita M, Toyama Y.

Bone. 2017 Feb;95:1-4. doi: 10.1016/j.bone.2016.10.027. Epub 2016 Oct 29.

PMID:
27989648
21.

Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents.

Katsuyama T, Sada KE, Yan M, Zeggar S, Hiramatsu S, Miyawaki Y, Ohashi K, Morishita M, Watanabe H, Katsuyama E, Takano-Narazaki M, Toyota-Tatebe N, Sunahori-Watanabe K, Kawabata T, Miyake K, Kiguchi T, Wada J.

Mod Rheumatol. 2017 Sep;27(5):773-777. doi: 10.1080/14397595.2016.1259714. Epub 2016 Dec 15.

PMID:
27846761
22.

Elemental analysis of occupational granulomatous lung disease by electron probe microanalyzer with wavelength dispersive spectrometer: Two case reports.

Tomioka H, Kaneda T, Katsuyama E, Kitaichi M, Moriyama H, Suzuki E.

Respir Med Case Rep. 2016 Apr 26;18:66-72. doi: 10.1016/j.rmcr.2016.04.009. eCollection 2016.

23.

Bilateral Abducens Nerve Palsy due to Idiopathic Intracranial Hypertension as an Initial Manifestation of Systemic Lupus Erythematosus.

Katsuyama E, Sada KE, Tatebe N, Watanabe H, Katsuyama T, Narazaki M, Sugiyama K, Watanabe KS, Wakabayashi H, Kawabata T, Wada J, Makino H.

Intern Med. 2016;55(8):991-4. doi: 10.2169/internalmedicine.55.5990. Epub 2016 Apr 15.

24.

Vitamin D Deficiency with High Intact PTH Levels is More Common in Younger than in Older Women: A Study of Women Aged 39-64 Years.

Miyamoto T, Katsuyama E, Kanagawa H, Fujie A, Miyamoto H, Yoshida S, Mori T, Miyamoto K, Sato Y, Kobayashi T, Nakamura M, Matsumoto M, Nishiwaki Y, Hirose H, Kanda T, Saito I, Toyama Y.

Keio J Med. 2016 Jun 25;65(2):33-8. doi: 10.2302/kjm.2015-0010-OA. Epub 2016 Feb 5.

25.

The efficacy of add-on tacrolimus for minor flare in patients with systemic lupus erythematosus: a retrospective study.

Watanabe H, Yamanaka R, Sada KE, Zeggar S, Katsuyama E, Katsuyama T, Narazaki MT, Tatebe NT, Sugiyama K, Watanabe KS, Wakabayashi H, Kawabata T, Wada J, Makino H.

Lupus. 2016 Jan;25(1):54-60. doi: 10.1177/0961203315600538. Epub 2015 Aug 21.

PMID:
26296361
26.

Methotrexate inhibits osteoclastogenesis by decreasing RANKL-induced calcium influx into osteoclast progenitors.

Kanagawa H, Masuyama R, Morita M, Sato Y, Niki Y, Kobayashi T, Katsuyama E, Fujie A, Hao W, Tando T, Watanabe R, Miyamoto K, Morioka H, Matsumoto M, Toyama Y, Saya H, Miyamoto T.

J Bone Miner Metab. 2016 Sep;34(5):526-31. doi: 10.1007/s00774-015-0702-2. Epub 2015 Jul 23.

PMID:
26202855
27.

Hyperglycemia Promotes Schwann Cell De-differentiation and De-myelination via Sorbitol Accumulation and Igf1 Protein Down-regulation.

Hao W, Tashiro S, Hasegawa T, Sato Y, Kobayashi T, Tando T, Katsuyama E, Fujie A, Watanabe R, Morita M, Miyamoto K, Morioka H, Nakamura M, Matsumoto M, Amizuka N, Toyama Y, Miyamoto T.

J Biol Chem. 2015 Jul 10;290(28):17106-15. doi: 10.1074/jbc.M114.631291. Epub 2015 May 21.

28.

IgG4-related Kidney Disease in Which the Urinalysis, Kidney Function and Imaging Findings Were Normal.

Otani M, Morinaga M, Nakajima Y, Tomioka H, Nishii M, Inoue Y, Ikeda T, Morimoto M, Katsuyama E, Tsunoda S.

Intern Med. 2015;54(10):1253-7. doi: 10.2169/internalmedicine.54.3259. Epub 2015 May 15.

29.

Risk factors for the development of glucocorticoid-induced diabetes mellitus.

Katsuyama T, Sada KE, Namba S, Watanabe H, Katsuyama E, Yamanari T, Wada J, Makino H.

Diabetes Res Clin Pract. 2015 May;108(2):273-9. doi: 10.1016/j.diabres.2015.02.010. Epub 2015 Feb 21.

PMID:
25765669
30.

Bcl6 promotes osteoblastogenesis through Stat1 inhibition.

Fujie A, Funayama A, Miyauchi Y, Sato Y, Kobayashi T, Kanagawa H, Katsuyama E, Hao W, Tando T, Watanabe R, Morita M, Miyamoto K, Kanaji A, Morioka H, Matsumoto M, Toyama Y, Miyamoto T.

Biochem Biophys Res Commun. 2015 Feb 13;457(3):451-6. doi: 10.1016/j.bbrc.2015.01.012. Epub 2015 Jan 15.

PMID:
25597995
31.

Interleukin-1 receptor-associated kinase-4 (IRAK4) promotes inflammatory osteolysis by activating osteoclasts and inhibiting formation of foreign body giant cells.

Katsuyama E, Miyamoto H, Kobayashi T, Sato Y, Hao W, Kanagawa H, Fujie A, Tando T, Watanabe R, Morita M, Miyamoto K, Niki Y, Morioka H, Matsumoto M, Toyama Y, Miyamoto T.

J Biol Chem. 2015 Jan 9;290(2):716-26. doi: 10.1074/jbc.M114.568360. Epub 2014 Nov 17.

32.

The vitamin D analogue ED71 but Not 1,25(OH)2D3 targets HIF1α protein in osteoclasts.

Sato Y, Miyauchi Y, Yoshida S, Morita M, Kobayashi T, Kanagawa H, Katsuyama E, Fujie A, Hao W, Tando T, Watanabe R, Miyamoto K, Morioka H, Matsumoto M, Toyama Y, Miyamoto T.

PLoS One. 2014 Nov 6;9(11):e111845. doi: 10.1371/journal.pone.0111845. eCollection 2014.

33.

An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case report focusing on a diagnostic pitfall.

Kataoka TR, Yamashita N, Furuhata A, Hirata M, Ishida T, Nakamura I, Hirota S, Haga H, Katsuyama E.

World J Surg Oncol. 2014 Jun 18;12:186. doi: 10.1186/1477-7819-12-186.

34.

Reversed halo sign in pulmonary infarction with tumor emboli: a case report.

Goshima H, Tomioka H, Nishio C, Fujii H, Katsuyama E.

Respir Investig. 2014 May;52(3):199-202. doi: 10.1016/j.resinv.2013.08.004. Epub 2013 Sep 7.

PMID:
24853022
35.

Mycobacterium tuberculosis promotes arthritis development through Toll-like receptor 2.

Kanagawa H, Niki Y, Kobayashi T, Sato Y, Katsuyama E, Fujie A, Hao W, Miyamoto K, Tando T, Watanabe R, Morita M, Morioka H, Matsumoto M, Toyama Y, Miyamoto T.

J Bone Miner Metab. 2015 Mar;33(2):135-41. doi: 10.1007/s00774-014-0575-9. Epub 2014 Mar 15.

PMID:
24633489
36.

TNFα promotes osteosarcoma progression by maintaining tumor cells in an undifferentiated state.

Mori T, Sato Y, Miyamoto K, Kobayashi T, Shimizu T, Kanagawa H, Katsuyama E, Fujie A, Hao W, Tando T, Iwasaki R, Kawana H, Morioka H, Matsumoto M, Saya H, Toyama Y, Miyamoto T.

Oncogene. 2014 Aug 14;33(33):4236-41. doi: 10.1038/onc.2013.545. Epub 2013 Dec 16.

PMID:
24336323
37.

AP-VAS 2012 case report: anti-glomerular basement membrane disease with high titer of myeloperoxidase anti-neutrophil cytoplasmic antibody-an autopsy case report.

Otani M, Shoji H, Tomioka H, Kaneda T, Kida Y, Kaneko M, Fujii H, Nakajima Y, Katsuyama E.

CEN Case Rep. 2013 Nov;2(2):154-157. doi: 10.1007/s13730-013-0059-0. Epub 2013 Apr 10.

38.

HIF1α is required for osteoclast activation by estrogen deficiency in postmenopausal osteoporosis.

Miyauchi Y, Sato Y, Kobayashi T, Yoshida S, Mori T, Kanagawa H, Katsuyama E, Fujie A, Hao W, Miyamoto K, Tando T, Morioka H, Matsumoto M, Chambon P, Johnson RS, Kato S, Toyama Y, Miyamoto T.

Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):16568-73. doi: 10.1073/pnas.1308755110. Epub 2013 Sep 10.

39.

Comparison of postoperative morbidity between simultaneous bilateral and staged bilateral total knee arthroplasties: serological perspective and clinical consequences.

Niki Y, Katsuyama E, Takeda Y, Enomoto H, Toyama Y, Suda Y.

J Arthroplasty. 2014 Mar;29(3):504-9. doi: 10.1016/j.arth.2013.07.019. Epub 2013 Aug 27.

PMID:
23988436
40.

[Three autopsy cases of chronic necrotizing pulmonary aspergillosis].

Mamesaya N, Tomioka H, Kaneda T, Kida Y, Kaneko M, Fuji H, Katsuyama E.

Kansenshogaku Zasshi. 2012 Sep;86(5):597-603. Japanese.

PMID:
23198580
41.

An essential role for STAT6-STAT1 protein signaling in promoting macrophage cell-cell fusion.

Miyamoto H, Katsuyama E, Miyauchi Y, Hoshi H, Miyamoto K, Sato Y, Kobayashi T, Iwasaki R, Yoshida S, Mori T, Kanagawa H, Fujie A, Hao W, Morioka H, Matsumoto M, Toyama Y, Miyamoto T.

J Biol Chem. 2012 Sep 21;287(39):32479-84. Epub 2012 Aug 3.

42.

Conditional inactivation of Blimp1 in adult mice promotes increased bone mass.

Miyauchi Y, Miyamoto H, Yoshida S, Mori T, Kanagawa H, Katsuyama E, Fujie A, Hao W, Hoshi H, Miyamoto K, Sato Y, Kobayashi T, Akiyama H, Morioka H, Matsumoto M, Toyama Y, Miyamoto T.

J Biol Chem. 2012 Aug 17;287(34):28508-17. doi: 10.1074/jbc.M112.356634. Epub 2012 Jul 3.

43.

Case of interstitial lung disease with anti-EJ and anti-CCP antibodies preceding rheumatoid arthritis.

Tomioka H, Kaneko M, Kogata Y, Katsuyama E, Ishikawa S, Fujii T.

Respir Investig. 2012 Jun;50(2):66-9. doi: 10.1016/j.resinv.2012.04.003. Epub 2012 May 17.

PMID:
22749253
44.

PDGFBB promotes PDGFRα-positive cell migration into artificial bone in vivo.

Yoshida S, Iwasaki R, Kawana H, Miyauchi Y, Hoshi H, Miyamoto H, Mori T, Kanagawa H, Katsuyama E, Fujie A, Hao W, Kobayashi T, Sato Y, Miyamoto K, Morioka H, Matsumoto M, Chiba K, Toyama Y, Nakagawa T, Miyamoto T.

Biochem Biophys Res Commun. 2012 May 18;421(4):785-9. doi: 10.1016/j.bbrc.2012.04.084. Epub 2012 Apr 23.

PMID:
22554514
45.

Aldehyde-stress resulting from Aldh2 mutation promotes osteoporosis due to impaired osteoblastogenesis.

Hoshi H, Hao W, Fujita Y, Funayama A, Miyauchi Y, Hashimoto K, Miyamoto K, Iwasaki R, Sato Y, Kobayashi T, Miyamoto H, Yoshida S, Mori T, Kanagawa H, Katsuyama E, Fujie A, Kitagawa K, Nakayama KI, Kawamoto T, Sano M, Fukuda K, Ohsawa I, Ohta S, Morioka H, Matsumoto M, Chiba K, Toyama Y, Miyamoto T.

J Bone Miner Res. 2012 Sep;27(9):2015-23. doi: 10.1002/jbmr.1634.

46.

Osteoclast stimulatory transmembrane protein and dendritic cell–specific transmembrane protein cooperatively modulate cell–cell fusion to form osteoclasts and foreign body giant cells.

Miyamoto H, Suzuki T, Miyauchi Y, Iwasaki R, Kobayashi T, Sato Y, Miyamoto K, Hoshi H, Hashimoto K, Yoshida S, Hao W, Mori T, Kanagawa H, Katsuyama E, Fujie A, Morioka H, Matsumoto M, Chiba K, Takeya M, Toyama Y, Miyamoto T.

J Bone Miner Res. 2012 Jun;27(6):1289-97. doi: 10.1002/jbmr.1575.

47.

Comparison between mucinous cystic neoplasm and intraductal papillary mucinous neoplasm of the branch duct type of the pancreas with respect to expression of CD10 and cytokeratin 20.

Nishigami T, Onodera M, Torii I, Sato A, Tao LH, Kushima R, Kakuno A, Kishimoto M, Katsuyama E, Fujimori T, Hirano H, Satake M, Kuroda N, Nishiguchi S, Fujimoto J, Tsujimura T.

Pancreas. 2009 Jul;38(5):558-64. doi: 10.1097/MPA.0b013e31819f3bd6.

PMID:
19287335
48.

[Value of 18F-fluorodeoxyglucose-PET in the diagonosis and monitoring of pulmonary sarcoidosis: a case report].

Kaneko M, Tomioka H, Kaneda T, Kubot M, Tani S, Fujii H, Katsuyama E, Okazaki M.

Nihon Kokyuki Gakkai Zasshi. 2008 Jun;46(6):505-9. Japanese.

PMID:
18593000
49.

Angiosarcoma of the breast - specific findings of MRI.

Kikawa Y, Konishi Y, Nakamoto Y, Harada T, Takeo M, Ogata M, Yamamoto M, Usuki N, Toyoshima M, Katsuyama E.

Breast Cancer. 2006;13(4):369-73.

50.

Late-onset familial amyloid polyneuropathy: an autopsy study of two Japanese brothers.

Fujitake J, Mizuta H, Fujii H, Ishikawa Y, Katsuyama E, Takasu K, Saida K, Tatsuoka Y.

Amyloid. 2003 Sep;10(3):198-205.

PMID:
14640033

Supplemental Content

Loading ...
Support Center